Navigation Links
MSU technology spin-out company to market portable biohazard detection
Date:1/27/2012

EAST LANSING, Mich. --- A new company formed around Michigan State University nanotechnology promises to move speedy detection of deadly pathogens and toxins from the laboratory directly to the field.

Food contamination and other biohazards present a growing public health concern, but laboratory analysis consumes precious time. The company, nanoRETE, will develop and commercialize an inexpensive test for handheld biosensors to detect a broad range of threats such as E. coli, Salmonella, anthrax and tuberculosis.

A significant leap forward in detection and diagnostic technology, it utilizes novel nanoparticles with magnetic, polymeric and electrical properties developed by Evangelyn Alocilja, MSU professor of biosystems and agricultural engineering and chief scientific officer of nanoRETE.

"Our unique preparation, extraction and detection protocol enables the entire process to be conducted in the field, without significant training," Alocilja said. "Results are generated in about an hour from receipt of sample to final readout, quickly identifying contaminants so that proper and prompt actions can be taken."

The mobile technology comes at only a fraction of the cost of the closest currently available competing technology, company officials said.

"Although the technology originates from research for biodefense applications, its potential reaches far beyond the initial scope," said Fred Beyerlein, CEO of nanoRETE. "Our X-MARK platform-based technology has the ability to detect multiple pathogens or toxins at one time, in a rapid, point-of-use, cost-effective manner. Imagine the potential applications for food growers, packagers or sellers. Contaminated food or water could be quickly identified, isolated and resolved before reaching the ultimate consumer you or me."

nanoRETE is backed by Michigan Accelerator Fund I, a Grand Rapids, Mich., investment partnership focused on Michigan-based early stage life science and technology companies.

"Our task was to find promising technologies, identify strong management and support with investment dollars," MAF-1 managing director Dale Grogan said. "We reviewed literally hundreds of technologies developed within MSU and determined that this particular technology best fit our investment model. We are excited about nanoRETE's future and hope this is the first of many companies we help develop with MSU."

MSU Technologies, the office that manages technology transfer at MSU, was actively involved in licensing the technologies to nanoRETE. In addition to other grants, the technologies earned funding from the MSU Foundation to continue development across the financial "valley of death" between research and commercialization.

"We have had great faith that Dr. Alocilja's work in nano-scale detection would be a very successful platform on which to start a new company," said Charles Hasemann, executive director of MSU Technologies. "MAF-1 has been a great partner in building nanoRETE. With its partnership and investment, we expect to move rapidly to a marketable product."


'/>"/>

Contact: Sandy Cameron
camer101@msu.edu
517-884-1828
Michigan State University
Source:Eurekalert  

Related biology news :

1. PNNL recognized for technology transfer
2. Nanotechnology in Medical Applications: The Global Market
3. T-rays technology could help develop Star Trek-style hand-held medical scanners
4. 2012 Biotechnology and Pharmaceuticals: Forthcoming Conferences and Exhibitions
5. BGI enters agreement with National Center for Soybean Biotechnology to re-sequence 1,008 soybean lines
6. Neurotechnology Announces VeriFinger, VeriLook and MegaMatcher Biometric Technologies for the Android Platform
7. White House official heads keynote speakers at Carbon Management Technology Conference
8. Naval technology could be a lifesaver
9. Exploiting Trichoderma: From food security to biotechnology
10. UCF nanotechnology may speed up drug testing
11. 2 research facilities awarded technology seeding grants
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
MSU technology spin-out company to market portable biohazard detection
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
(Date:6/1/2016)... June 1, 2016 Favorable Government ... Administration and Criminal Identification to Boost Global Biometrics System ... released TechSci Research report, " Global Biometrics Market ... Forecast and Opportunities, 2011 - 2021", the global biometrics ... 2021, on account of growing security concerns across various ...
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Global demand for ... percent through 2020 to $7.2 billion.  This market ... beverages, cleaning products, biofuel production, animal feed, and ... diagnostics, and biocatalysts). Food and beverages will remain ... by increasing consumption of products containing enzymes in ...
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology: